Vol 7, Issue 4
Pages 579–584
Published: 15 Dec 2025
Lanny L. Johnson1*, Peter Chen2, Darryl D’Lima, PhD3
Article Information
Citation: Lanny L. Johnson, Peter Chen, Darryl D’Lima. Protocatechuic Acid Promotes Osteoblast Differentiation of Human Mesenchymal Stem Cells: Impact on Bone Metabolism, Osteoporosis and Fractures. Journal of Orthopedics and Sports Medicine. 7 (2025): 579-584.
DOI: 10.26502/josm.511500244
Share
Abstract
Protocatechuic acid (PCA) is found throughout nature, common to the human diet and produced daily by the bacteria in human large bowel microbiome. PCA, a food supplement, is safe by any measure; non-toxic, non-allergenic and non-mutagenic. Our in vitro results revealed that PCA promotes osteoblast differentiation in human mesenchymal stem cell (MSC) cultures, as indicated by increased expression of SSP1, RUNX2, and ALPL and calcium deposition. These results may ultimately lead to the use of PCA, a nutraceutical, for the treatment of metabolic bone disorders, osteoporosis, and fractures.
Keywords
Mesenchymal stem cells; Osteoblasts; Protocatechuic acid; Osteoporosis; Osteopenia; Bone fracture
Article Details
1. Introduction